FOGHORN THERAPEUTICS I
7.8162
07-十月-24 10:09:39
15 分钟延时
股票
-0.0138
-0.18%
今日范围
7.5000 - 7.8300
ISIN
N/A
来源
NASDAQ
-
Foghorn Therapeutics to Present at Connective Tissue Oncology Society Annual Meeting
14 11月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Third Quarter 2022 Financial and Corporate Update
08 11月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Appoints Dr. Thomas J. Lynch, Jr. to Its Board of Directors
27 10月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
26 10月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Present at Hanson Wade's 5th Annual Targeted Protein Degradation Summit
20 10月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate in the Bank of America 2022 Precision Oncology Conference
27 9月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces Participation in Upcoming Investor Conferences
01 9月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces Change to Board of Directors
31 8月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Further Update on FHD-286 Phase I Study in Relapsed/Refractory AML/MDS
23 8月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Appoints Lynne Parshall to its Board of Directors
17 8月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Second Quarter 2022 Financial and Corporate Update
09 8月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces Upcoming Investor Conference Participation
31 5月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
19 5月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides First Quarter 2022 Corporate Update
09 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
13 4月 2022 11:30:00 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Present Preclinical Data For FHD-286 at the 2022 AACR Annual Meeting
01 4月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the 2022 Guggenheim Targeted Protein Degradation Day
11 3月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Full Year 2021 Corporate Update and 2022 Outlook
10 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the Cowen’s 42nd Annual Health Care Conference
28 2月 2022 16:05:01 条件 Nasdaq GlobeNewswire